Pharmafile Logo
Pharmafocus logo
Advanced Search

VSV-ZEBOV

Showing 3 posts of 3 posts found.

Ebola virus

Researchers hopeful experimental antiviral treatment stops Ebola

August 26, 2015
Research and Development Ebola, Ebola virus, Ebola virus disease, Toyama Chemical, VSV-ZEBOV, favipiravir, zmapp

An experimental antiviral therapy may have prevented British healthcare workers from contracting Ebola after exposure to the disease in West …

News
Merck image

Merck Ebola vaccine safe and effective in latest trials

April 2, 2015
Research and Development, Sales and Marketing Ebola, Merck, National Institutes of Health, VSV-ZEBOV, Vaccine, Walter Reed Army Institute of Research, newlink

Merck and NewLink’s experimental Ebola vaccine has been found to be safe and effective in a new trial in the …

News
Merck image

Merck Ebola vaccine shows promise

December 4, 2014
Research and Development, Sales and Marketing Ebola, Merck, VSV-ZEBOV, WHO, hug, newlink genetics

Merck and NewLink Genetics’ experimental Ebola vaccine has shown no major side effects in its first trial according to the …

News
The Gateway to Local Adoption Series

Latest content

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026

AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trials

October 4, 2026

Brenntag and dsm-firmenich expand biopharma vitamin partnership

October 4, 2026